Back to All Events

ACTC 2025


  • Thessaloniki Greece (map)

BLOODPAC at the 7th Advances in Circulating Tumor Cells Meeting
September 24–27, 2025 | Thessaloniki, Greece

BLOODPAC is pleased to participate in the 7th Advances in Circulating Tumor Cells (ACTC) meeting, “Liquid Biopsy: From Bench to Bedside.” Our dedicated session will take place on Saturday, September 27, 2025, from 11:00 AM – 12:00 PM.

The session will feature a series of four short presentations (10 minutes each), followed by a panel discussion and closing remarks.

Session Speakers

  • Lauren Leiman – Executive Director, Blood Profiling Atlas in Cancer (BLOODPAC), USA

  • Frank Diehl – Executive Vice President & Head of Product Solutions, Exact Sciences, USA (Presentation #1 TBA)

  • Bree Mitchell – Senior Director, Translational Medicine and Innovation, Natera, USA (Presentation #2 TBA)

  • Peter Kuhn, PhD – University Professor and Director of CSI-Cancer, University of Southern California, Los Angeles, California, USA (Presentation #3 TBA)

Previous
Previous
September 3

BLOODPAC 2025 Q3 Meeting

Next
Next
October 8

2025 Prevent Cancer Dialogue